Christopher Sciarpelletti is a dynamic Director with over 15 years of experience in biopharmaceutical process development and manufacturing. Currently serving as the Director of MSAT at CARGO Therapeutics, they direct technology transfer and comparability efforts to enhance cell therapy programs. Christopher has previously held positions at Anacor Pharmaceuticals, Hitachi Chemical Advanced Therapeutics Solutions, and MannKind Corporation, where they developed expertise in cGMP, quality by design, and risk management. They earned a Bachelor of Science in Chemical Engineering from Worcester Polytechnic Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices